"I hope we don't go back to doing business as usual," Johnson & Johnson CEO Alex Gorsky said in an interview with the Washington Post.

In its S-1 filing, Oscar Health laid out its financials, its risks, and its dual-class stock structure.

A meeting with lawmakers Wednesday was expected to start the efforts by Biden, whose son died of brain cancer in 2015, to boost the search for a cure.

The US could distribute 500 million doses by the end of May — enough to vaccinate all of its adult population.

Download this FREE report where Insider Intelligence details five companies working to address consumers' growing virtual care needs.

DispatchHealth raised $200 million from Tiger Global and other top investors with a presentation obtained by Insider.

Atai Life Sciences recently raised $157 million in its Series D funding round, and reports say its looking at a possible public listing.

Some fast-food restaurants in Los Angeles County failed to follow COVID-19 protocols and kept infections a secret, according to a new report.

Biden told states to treat in-person learning as an essential service, which means prioritizing the vaccination of educators regardless of age.

Insider identified the psychedelics companies that raised the most funding in 2020. Atai, at the top of our list, raised $125 million in November.

Kentaro Yoshifuji of OryLab is one of a number of entrepreneurs experimenting in the avatar robot field

These are Insider's biggest healthcare stories for March 3.

For diabetics who lack electricity at home, a shift in how insulin is handled could be game-changing.

As Texas ended its mask mandate, Mississippi, Louisiana, and Michigan — as well as Chicago and San Francisco — all eased some COVID-19 restrictions.

Beverly Anderson has been working with D.C. police for decades as an independent psychologist. Since Jan. 6, she's been treating officers for trauma.

Biotech investor Arch Venture Partners and tech investor General Catalyst have teamed up on a SPAC focused on mental health and/or virtual health.

CEO Florian Brand told Insider that the money will be used to "double down" on the company's existing strategy.

Major retail stores Macy's and Target are sticking to federal advice and requiring all customers and employees to wear masks in Texas stores.

AstraZeneca sold its 7.7% stake in vaccine producer Moderna for around $1 billion last year, a "large proportion" of its 2020 equity portfolio sales.

Business Insider has rounded up the six-top earning positions in the cultivation, extraction, manufacturing, and retail sectors of cannabis.

The Digital Health Briefing is a curated, subscriber-only daily email newsletter from Insider Intelligence with insight into the future of healthcare.

Insider Intelligence examines the top five US startups in the areas of digital health with the most number of deals in the first half of 2020.

Spanish startup HumanITCare went from 3 clients to 20 during the coronavirus health crisis and expects to end 2021 with a turnover of $1.2 million.

Humana's investments in primary-care clinics are part of its strategy to integrate insurance and care delivery to provide better care to seniors.

Some experts advocate waiving second vaccine shots for those who have had COVID-19 — but others think the approach is too risky.

The Washington Post reported that President Joe Biden would announce the partnership between the two US pharmaceutical giants.

Startups looking at new ways to pay for and provide care like Cityblock Health and VillageMD collectively raised $3.6 billion in 2020.

The world will need multiple effective coronavirus vaccines to combat this pandemic. Here's the latest news on the frontrunners.

BridgeBio just received FDA approval for its first drug for an ultra-rare disease. It's the first proof-point for a company that drew skepticism.

These are Insider's biggest healthcare stories for March 2.

Gregory Armstrong, of the CDC, told Bloomberg 585 cases of the variant first found in New York have emerged in the US in the past two weeks.

CEO Stanley Erck said Novavax's COVID-19 vaccine could be authorized in the UK first before the FDA gives it emergency-use authorization.

Here's how tech giants and digital health companies are using their tech and clinical expertise to help US businesses with their reopening plans.

Some people might prefer Johnson & Johnson's shot because it was tested on variants, has milder side effects, and is easier to get.

This table shows the differences among the COVID-19 vaccines from Pfizer-BioNTech, Moderna, Johnson & Johnson, and AstraZeneca-Oxford University.

Retailers like Walmart changed their approaches to take on the healthcare industry after the pandemic hit. Here's an update on their plans.

Eighteen doctors and scientists share their predictions and plans for this summer, from sleepaway camp to national-park trips.

Relationships expert Dr. Lamarche said that it could motivate younger groups on dating apps who might feel disincentivized to get a COVID-19 vaccine.

Insider Intelligence explores the drivers lighting a fire under the DTx market and unpacks the ways vendors reach their intended audiences.

These are Insider's biggest healthcare stories for March 1.

Experts are investigating COVID-19 variants first found in the UK, South Africa, and Brazil, including whether vaccines work on them. Here's what we know.

COVID-19 vaccines will likely be available for high-school children in the fall, and for elementary-school children in early 2022, Dr. Anthony Fauci said.

One of the people identified as having P.1, the variant first found in Brazil, didn't complete a registration form, so officials don't know who it is.

Insider Intelligence examines some of the major effects of the pandemic's spread on healthcare costs, as well as vaccine progress.

Insider Intelligence explores factors driving burnout among clinicians, and how digital health firms and big tech are developing AI solutions.

The Digital Health Briefing is a curated, subscriber-only daily email newsletter from Insider Intelligence with insight into the future of healthcare.

The novelist Julia Dahl reaches out to fellow writers like Kate Reed Petty, Jodi Picoult, and S.A. Cosby to ask how they are handling the coronavirus.